Skip to Content

Nedocromil Pregnancy and Breastfeeding Warnings

Nedocromil is also known as: Tilade

Nedocromil Pregnancy Warnings

Nedocromil has been assigned to pregnancy category B by the FDA. Animal studies using doses of 100 mg/kg/day subcutaneously have not revealed evidence of adverse fetal outcome. There are no controlled data in human pregnancy. Nedocromil is only recommended for use during pregnancy when benefit outweighs risk.

See references

Nedocromil Breastfeeding Warnings

There are no data on the excretion of nedocromil into human milk. The manufacturer recommends that caution be used when administering nedocromil to nursing women,

See references

References for pregnancy information

  1. "Product Information. Tilade (nedocromil)." Rhone-Poulenc Rorer, Collegeville, PA.
  2. Mcdonald CF, Burdon JGW "Asthma in pregnancy and lactation - a position paper for the thoracic society of australia and new zealand." Med J Aust 165 (1996): 485-8
  3. Dombrowski MP "Pharmacologic therapy of asthma during pregnancy." Obstet Gynecol Clin North Am 24 (1997): 559

References for breastfeeding information

  1. Mcdonald CF, Burdon JGW "Asthma in pregnancy and lactation - a position paper for the thoracic society of australia and new zealand." Med J Aust 165 (1996): 485-8
  2. "Product Information. Tilade (nedocromil)." Rhone-Poulenc Rorer, Collegeville, PA.

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.

Hide